ADOLOR CORP ADLR (NASDAQ)

$ 3.06
19:09
Change: +0.01 (+0.33%)
Volume: 322,000

Avg. Volume: 393600
P/E Ratio: 0
EPS (Annual): -0.55
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 46,030
Institutional Shareholders: 73.60%
Last: 3.06
Change: +0.01 (+0.33%)
Prev. Close: 3.05
Open: 3.00
Day's Range: 2.94 - 3.06
52wk Range: 2.92 - 6.09
Market Value: 141,230
Beta: -.43
12-month EPS Change: 0.00%
Total Return Last 12 Months: -19.26%
Total Return Last 3 Years: -177.31%
Total Return Last 5 Years: -80.09%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on ADLR

Study: You can chew gum and get well at same time

(CHICAGO)Can you chew gum and recover from surgery at the same time? British researchers say it's a great idea for some patients. Chewing gum may speed the return of normal bowel function a...READ MORE
Aug 18, 2008 4:02PM
Keywords: ADLR

FDA lifts clinical hold on Adolor bowel drug

(EXTON, Pa.)Adolor Corp. said Thursday the Food and Drug Administration has lifted its clinical hold on the company's Entereg drug in chronically constipated patients taking opioid pain drugs....READ MORE
Jul 03, 2008 8:33AM
Keywords: ADLR, GSK

Russell 2000 adds 53 health care companies

(NEW YORK)More than 50 companies in the health care sector were added to the Russell 2000 in this year's reconstitution of the small stock index, while 30 companies in the sector were re...READ MORE
Jun 30, 2008 2:16PM

Adolor appoints Stephen W. Webster as CFO

(EXTON, Pa.)Biopharmaceutical company Adolor Corp. said Friday it appointed Stephen W. Webster as chief financial officer, effective on or about June 30. Webster succeeds Thomas Hess, who has ...READ MORE
Jun 13, 2008 3:18PM
Keywords: ADLR

Wyeth, Progenics drug misses goal in late-stage trial

(COLLEGEVILLE, Pa.)Wyeth and Progenics Pharmaceuticals Inc. said Thursday that early results from a late-stage trial of their drug Relistor did not meet its goal in restoring gastrointestinal functio...READ MORE
May 22, 2008 9:40AM
Keywords: PGNX, ADLR, WYE

Partnerships drive big stock gains for small biotechs

(NEW YORK)As growth slows in shares of large-cap biotechs and economic woes weigh on the broader markets, investors can find dramatic growth opportunities in many small and midcap biotechs w...READ MORE
May 21, 2008 4:58PM

Out of the Gate: Adolor jumps on Entereg approval

(NEW YORK)Shares of Adolor Corp. climbed to a fresh annual high Wednesday, after regulators approved its constipation treatment Entereg, but analysts were divided on sales prospects for the ...READ MORE
May 21, 2008 10:11AM
Keywords: ADLR, GSK
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +28.80 60.41
AMYLIN PHARMA I -56.90 21.11
GILEAD SCIENCES +15.20 47.85
BIOGEN IDEC INC -20.40 48.59
GENENTECH INC +33.90 96.64